Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases

Reuters
25 Mar
March 25 (Reuters) - Quoin Pharmaceuticals Ltd <2EBy.BE>::
*QUOIN PHARMACEUTICALS FILES U.S. PATENT APPLICATION FOR NOVEL TOPICAL FORMULATIONS TO TREAT NETHERTON SYNDROME AND OTHER SKIN DISEASES
*QUOIN PHARMACEUTICALS LTD - IF GRANTED, PATENT WOULD PROVIDE PROTECTION FOR QRX003 UNTIL 2045

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 25-MAR-202511:30:00.367 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10